Multi-canceR Early-detection Test in Asymptomatic Individuals (PREVENT)
Recruiting now · Not applicable
Conditions studied: Cancer, Early Detection of Cancer, Circulating Cell-free DNA
In brief
PREVENT is a prospective, multicenter, interventional study evaluating the performance of the OverC multi-cancer detection blood test in asymptomatic individuals with cancer risk.
Key facts
- Study ID
- NCT05227534
- Run by
- Guangzhou Burning Rock Dx Co., Ltd.
- People needed
- 12500
- Starts
- 2022-06-01
- Expected to finish
- 2028-12-31
- Last updated by the study team
- 2022-07-06
Who can join
Age: 40 and older, up to 75. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Participants must be able to provide a written informed consent form
- Participants must not have received any colonoscopy, abdominal MRI/CT, low-dose CT, or chest CT within 5 years before signing the informed consent form
- Participants must be able to provide blood samples for study tests
- Participants must be between 40 and 75 years old
You may not qualify if…
- Individuals who have an acute infection or inflammation within 14 days prior to recruitment
- Individuals with cancer-associated clinical symptoms or suspected of cancer
- Recipient of organ transplant or prior non-autologous (allogeneic) bone marrow or stem cell transplant
- Recipient of blood transfusion within 7 days prior to recruitment
- Individuals who have pure ground-glass opacity
- Unable to provide blood samples for the multi-cancer early detection blood test
- Individuals who are unable to tolerate standard-of-care cancer screening tests or have contraindications of standard-of-care cancer screening tests
- Individuals who have taken medication with anti-tumor effects within 30 days prior to recruitment
- Individuals who have received or are undergoing curative cancer treatment within three years prior to recruitment
- Individuals with hemorrhagic diseases
- Individuals with autoimmune diseases
- Individuals who are pregnant or lactating
- Individuals who have severe comorbidities that are not suitable for participating in the trial judged by researchers
Where it is running
- West China Hospital, Sichuan University — Chengdu, Sichuan, China (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.